Fas is a well characterized apoptosis-inducing factor. One of our synthetic compounds, MT-21, induced apoptosis in human leukemia HL-60 cells similar to Fas. MT-21 activated caspase-3, an important cysteine aspartic protease for apoptosis induction. MT-21 also activated c-Jun-NH 2 -terminal kinase (JNK), a member of mitogen activated protein kinase (MAPK) superfamily that is involved in the regulation of cell growth, dierentiation and cell death. Moreover, MT-21 treatment resulted in the activation of a 36 kDa kinase which uses myelin basic protein (MBP) as a substrate. However, MAPK and p38 were not activated by treatment with MT-21. The 36 kDa MBP kinase was shown to be a proteolytic product derived from the Krs protein with a molecular weight of 60 kDa. The Krs protein is a Ser/Thr protein kinase whose activity is enhanced by digestion of its C-terminal regulatory domain by caspase-3. When a kinase-inactive mutant form of Krs protein was overexpressed in HL-60 cells, JNK activation and apoptosis induction by MT-21 were suppressed. Furthermore, overexpression of dominant negative c-Jun also suppressed apoptosis induction by MT-21. These ®ndings indicate that MT-21 induces apoptosis by the activation of JNK via the Krs protein, which is activated by caspase cleavage.
Introduction
The mechanism of apoptosis induction in various cancer cells has been intensely studied (Lazebnik et al., 1994; Casciola Rosen et al., 1995; Nicholson et al., 1995; Cryns et al., 1997; Orth et al., 1996; Takahashi et al., 1996; Mashima et al., 1997; Sakahira et al., 1998) . In particular, the elucidation of the mechanism of Fas-induced apoptosis is markedly advancing. Ligand binding to Fas activates a cascade of cysteine aspartic proteases (caspases) common to apoptotic processes (Longthorne et al., 1997) . Caspases are synthesized as precursors and proteolysed mature enzymes subsequently cleave other caspases in the cascade. Studies that aim to elucidate the mechanism of the caspase cascade often utilize Z-Asp as an inhibitor with a broad speci®city against various caspases. Moreover, the protease activity of the caspase-3 is inhibited by an acidic tetrapeptide aldehyde (Ac-DEAD-CHO) which mimics the target sequence, but not by a hydrophobic tetrapeptide aldehyde (Ac-YVAD-CHO) that was shown to inhibit another cysteine protease, caspase-1 ( . Thus, the discovery of caspase inhibitors has contributed to biochemical studies that seek to reveal the role of caspases in regulating important processes in mammalian cells. Activated caspases cleave various cellular substrates such as actin, poly (ADP-ribose) polymerase, fodrin, lamin and ICAD, which may be responsible for the morphological changes and DNA fragmentation (Lazebnik et al., 1994; Casciola Rosen et al., 1995; Nicholson et al., 1995; Cryns et al., 1997; Orth et al., 1996; Takahashi et al., 1996; Mashima et al., 1997; Sakahira et al., 1998) . Furthermore, caspases cleave components of signal transduction pathways such as D4-GDI, a regulator of Rho family GTPase , the p21 activated kinase-2 (PAK2) (Rudel and Bokoch, 1997) , the d and y isoforms of protein kinase C (PKC) (Emoto et al., 1995; Datta, 1995) , PKC-related kinase 2 (PRK2) (Cryns et al., 1997) , focal adhesion kinase (FAK) (Crouch et al., 1996) and MEKK1 (Cardone et al., 1997) . Caspases cleave and activate these protein kinases during apoptosis, suggesting that protein phosphorylation/dephosphorylation mechanisms play important roles in the initiation and execution of apoptosis.
Fas ligands may represent possible candidates for antitumor agents. However, most tumor cells expressed low level of Fas protein, moreover, it is dicult to use proteinous Fas ligands for cancer chemotherapy. Therefore, we have synthesized a series of g-lactam ring containing compounds to induce apoptosis. During these studies, we found that one of the compounds, MT-21, induced cell death in various cell lines, including rat pheochromocytoma PC12 cells and human leukemia HL-60 cells.
Recent studies have indicated that reactive oxygen species (ROS), including singlet oxygen, superoxide, hydrogen peroxide (H 2 O 2 ), hydroxyl radical and nitric oxide are involved in the signaling pathway for apoptosis (Jacobson, 1996; Simizu et al., 1996; Hockenbery et al., 1993) . Overexpression of Bcl-2, an apoptosis inhibitory protein, decreased ROS generation and increased resistance to apoptotic killing by H 2 O 2 , menadione and depletion of glutathione (Hockenbery et al., 1993) . However, whether ROS is essential for apoptosis induction remains to be investigated. In addition, little is known about the relationship between ROS, caspases and protein kinases.
One protein kinase activated by apoptosis-inducing stimulation is the 36 kDa MBP kinase which is known to be activated by UV irradiation, retinoic acid, okadaic acid, TNFa, serum starvation and cytotrienin A in various cell lines (Lu et al., 1996; Kakeya et al., 1998) . Activation of JNK has also been observed to correlate with apoptosis inducing agents, as well as nerve growth factor withdrawal, B-cell receptor crosslinking and Fas ligation (Xia et al., 1995; Cahill et al., 1996; Wilson et al., 1996) . Caspase inhibitors block JNK activation induced by Fas cross-linking, indicating that JNK functions on downstream of the caspase cascade (Cahill et al., 1996) . Although these results suggest that 36 kDa MBP kinase and JNK are activated by apoptosis-inducing stimuli, the molecular mechanism of their action is unknown. Here, we show that the MT-21-induced signal is transferred to nucleus through activation of the caspase cascade, the Krs protein and JNK.
Results

Induction of apoptosis in HL-60 cells by MT-21
We tested a series of g-lactam-related compounds for their ability to induce cell death in HL-60 cells and identi®ed MT-21 as a potent inducer of cell death in HL-60 cells (Figure 1 ). Treatment with 18 mM MT-21 killed 50% of cells (IC 50 18 mM) after 18 h. We examined whether or not the cell death induced by MT-21 is due to apoptosis. As shown in Figure 2a , MT-21 gave a ladder pattern typical of internucleosomal fragmentation, which is considered to be an early event in apoptosis. Signi®cant induction of apoptosis by MT-21 in HL-60 cells was observed by 6 h at the concentration of 40 mM (Figure 2b ). Next, we tested the eect of antioxidants on MT-21-induced apoptosis. N-acetylcysteine (NAC), a scavenger of H 2 O 2 , and a-tocopherol, a scavenger of lipid peroxida- Figure 2c . In fact, MT-21 induced ROS production during apoptosis (Figure 3 ). These results indicated that MT-21 induced apoptosis via ROS production in HL-60 cells.
Activation of caspase(s) by MT-21
Since caspase-3 is known to be important in the apoptotic process, we examined whether activity of caspase-3 in HL-60 cells might be altered by treatment with 40 mM MT-21. Caspase-3 consists of two subunits, p20 and p12, derived from a precursor protein (p32) by proteolytic processing. Therefore, we sought to detect changes in the amount of the large subunit of caspase-3, p20, by immunoblotting with an anti-caspase-3 antibody. As shown in Figure 4a , p20 began to increase 3 h after the start of the treatment with MT-21. To con®rm whether caspase-3 was actually activated by digestion of p32 to p20 and p12, we monitored proteolytic fragmentation of poly (ADP-ribose) polymerase (PARP) with a molecular mass of 116 kDa, which is a good substrate of caspase-3, by immunoblotting with anti-PARP antibody. As shown in Figure 4b , the intensity of the bands of PARP decreased signi®cantly 3 h after the start of treatment with MT-21. Next, we tested the eect of antioxidants on MT-21-induced activation of caspase-3. The treatment of cells with NAC and atocopherol suppressed the cleavage and the activation of caspase-3 by MT-21 (Figure 4a and b) . To determine whether the activation of caspase(s) by MT-21 is necessary to induce apoptosis, the eect of Z-Asp on the apoptosis induction by MT-21 was examined. As shown in Figure 4c , Z-Asp can inhibit the activation of caspase-3. The treatment of cells with Figure 4 Activation of caspase-3 by MT-21 and the eect of caspase inhibitor on DNA fragmentation. HL-60 cells were treated with 40 mM MT-21 for the indicated times in the absence or presence of 3 mM NAC or 0.6 mM a-tocopherol. Immunoblotting analysis was performed using speci®c antibodies to caspase-3 (a) and PARP (b). HL-60 cells were pretreated with dierent concentrations of Z-Asp and then treated with 40 mM MT-21 for 6 h. Immunoblotting analysis was performed using speci®c antibodies to caspase-3 and PARP (c). Cellular DNA extracted from the cells was analysed by agarose gel electrophoresis and stained with ethidium bromide (d) 50 mM Z-Asp completely inhibited DNA fragmentation induced by MT-21 ( Figure 4d ). These results indicated that it was necessary for the proteolytic activation of caspase(s) by ROS production to induce apoptosis.
Activation of JNK by MT-21
We tested the eect of MT-21 on JNK activation. Cell extracts treated with MT-21 were prepared at the indicated times and the kinase activity of JNK was measured using GST-c-Jun (1-79) as a substrate (Figure 5a ). The [ 32 P]GST-c-Jun bands increased in intensity beginning 3 h after the start of treatment with MT-21, and this corresponds with the activation of caspase-3. Quantitative estimation of the JNK activity measured by the incorporation of 32 P into GST-c-Jun indicated that the activity increased gradually for the ®rst 3 h and then markedly 4.5 h after the start of treatment with MT-21 ( Figure 5b ). Moreover, we examined phosphorylated state of JNKs by immunoblot with anti-phospho JNKs antibodies ( Figure 5c ). It revealed that phosphorylation levels of JNK were parallel with the kinase activity as shown in Figure  5a and b. JNK1 was activated stronger than JNK2. Next, we tested the eect of antioxidants on MT-21-induced activation of JNK. The treatment of cells with NAC and a-tocopherol suppressed the activation of JNK by MT-21 (Figure 5a and b). To con®rm whether the activation of JNK by MT-21 depends on the caspase cascade, we examined the eect of Z-Asp on the activation of JNK. As shown in Figure 5e , activation of JNK by MT-21 stimulation was signi®cantly inhibited by pretreatment of HL-60 cells with Z-Asp. This result indicates that the activation of JNK is dependent on the activation of caspases. Moreover, in order to examine the eect of MT-21 on other MAPK family kinases, we measured p38 activity. p38 is activated upon phosphorylation by MKK6, and its activity can be measured by checking the state of phosphorylation of p38 by immunoblotting with anti-phospho-p38 antibody. Our studies showed MT-21 did not induce the activation of p38 ( Figure 5d ). Moreover, because apoptosis induced by MT-21 revealed no eect by the treatment with SB203580 which is a speci®c inhibitor of p38, it Figure 5 Activation of JNK by MT-21 and the eect of caspase inhibitor on JNK activity. JNK activity in HL-60 cells that had been treated with 40 mM MT-21 in the absence or presence of 3 mM NAC or 0.6 mM a-tocopherol was determined using a complex of gluthathione agarose and GST-c-Jun (1-79) as described in Materials and methods (a). The intensities of bands of phosphorylated proteins were quanti®ed with Scanning Imager (Molecular Dynamics, CA, USA) (b). Immunoblotting analysis was performed using speci®c antibodies to JNK1, phospho-JNK1/2 (c), p38 and phospho-p38 (d). As the positive control on p38, HL-60 cells was treated with 0.6 M sorbitol for 30 min. HL-60 cells were pretreated with 100 mM Z-Asp and then treated with 40 mM MT-21 for the indicated times. JNK activity was determined as described in a (e) seems that p38 is little related to apoptosis induction of MT-21 (data not shown).
Activation of 36 kDa kinase by MT-21
We also examined the eect of MT-21 on ERK activity. The measurement of ERK activity was performed by an in-gel kinase assay using myelin basic protein (MBP) as a substrate. MT-21 did not induce the activation of ERK (Figure 6a ). Interestingly, we detected a marked induction of a 36 kDa kinase activity after 3 h (indicated by *). In addition, the appearance of the 36 kDa kinase activity apparently correlated with the disappearance of a 60 kDa kinase activity (indicated by **). We tested the eect of antioxidants on MT-21-induced activation of a 36 kDa kinase. The treatment of cells with NAC and a-tocopherol suppressed the activation of the 36 kDa kinase and the disappearance of a 60 kDa kinase activity by MT-21 (Figure 6a ). We also examined the eect of Z-Asp on the activation of the 36 kDa kinase induced by treatment with MT-21. As shown in Figures 4c and 6c , pretreatment of HL-60 cells with 100 mM Z-Asp completely inhibited DNA fragmentation, the activation of 36 kDa kinase and the disappearance of 60 kDa kinase activity induced by MT-21. In order to identify the 60 kDa kinase, we looked for a known kinase that migrated at this molecular mass and was sensitive to proteolysis, yielding a catalytically active 36 kDa fragment. One candidate was the Krs protein (MST), a ubiquitously expressed serine-threonine kinase of 60 kDa, which is homologous to the yeast Ste20 kinase (Creasy and Cherno, 1995; Taylor et al., 1996; Kakeya et al., 1998 ). An extract of MT-21-stimulated HL-60 cells was subjected to immunoblotting using anti-Krs-1 and Krs-2 antibody against the 60 kDa band. As shown in Figure 6b , both the Krs-1 and Krs-2 bands disappeared following treatment with MT-21, although this disappearance was inhibited by pretreatment of cells with Z-Asp (Figure 6d ). This result suggests that Krs proteins may be cleaved by caspases to generate active fragments which have a molecular weight about 36 kDa.
Overexpression of the kinase-inactive form of Krs proteins
It was known that Krs proteins are cleaved and activated by caspases during Fas-induced apoptosis, however, the contribution of Krs proteins to antitumor agents-induced apoptosis is unclear. To address this question, we constructed expression vectors of kinase-inactive Krs-1 or Krs-2 by mutating Lys56 of Krs-1 or Lys59 of Krs-2 to Arg. When these kinase-inactive Krs proteins were expressed in HL-60 cells, we examined the amount of expressed Krs protein as total amounts of Figure 6 Activation of MBP kinase by MT-21 and the eect of caspase inhibitor on the MBP kinase activity. MBP kinase activity in HL-60 cells that had been treated with 40 mM MT-21 in the absence or presence with 3 mM NAC or 0.6 mM a-tocopherol was analysed by electrophoresis on an SDS-polyacrylamide gel containing MBP as described in Materials and methods (a). Immunoblotting analysis was performed using speci®c antibodies to Krs-1 and Krs-2 (b). HL-60 cells were pretreated with dierent concentrations of Z-Asp and then treated with 40 mM MT-21 for 6 h. MBP kinase activity was determined as described in a (c).
Immunoblotting analysis was performed as described in b (d) endogenues and exogenues by immunoblotting (Figure 7a ). Under the condition that kinase-inactive Krs proteins were overexpressed, the activation of p36 kDa kinase and JNK after the treatment with MT-21 was measured. As shown in Figure 7b and c, the activation of p36 kDa kinase and JNK in response to MT-21 was observed in HL-60 cells that had been transfected with an empty vector. These activations were almost completely suppressed by the expression of either of the inactive kinases, Krs-1 or Krs-2. These results raised the possibility that the DNA fragmentation induced by MT-21 would be inhibited by the expression of these kinase-inactive Krs proteins. Indeed, the DNA fragmentation induced by the treatment of MT-21 was eliminated in cells that had been transfected with kinase-inactive Krs proteins (Figure 7d ). These results suggest that JNK activity is exerted downstream of the Krs proteins, and the apoptosis induced by MT-21 in HL-60 cells is inhibited by blocking the signal that activates the Krs proteins.
The eect of dominant negative c-Jun on MT-21-induced apoptosis
In order to con®rm the role of JNK activation by active Krs proteins in the induction of apoptosis by MT-21, we examined the eect of expressing dominant negative c-Jun. The dominant negative cJun, lacking the transactivation domain, is able to dimerize with members of the c-Jun and c-Fos family and bind to DNA, but the dimers no not have transactivation activity. MT-21 treated U937 cells expressing dominant negative c-Jun were examined for apoptosis-induced DNA fragmentation. As shown in Figure 8a , DNA fragmentation Figure 7 The eect of kinase-inactive Krs proteins on the activation of MBP kinase, JNK and on DNA fragmentation by MT-21. HL-60 cells had been transfected with kinase-inactive Krs-1 and Krs-2. Immunoblotting analysis was performed using speci®c antibodies to Krs-1 and Krs-2 (a). HL-60 cells had been transfected with kinase-inactive Krs-1 and Krs-2 were treated with 40 mM MT-21 for 6 h. MBP kinase activity was analysed by electrophoresis on an SDS-polyacrylamide gel containing MBP as described under Materials and methods (b). JNK activity was determined using a complex of glutathione agarose and GST-c-Jun (1-79) as described under Materials and methods (c). Cellular DNA extracted from the cells was analysed by agarose gel electrophoresis and stained with ethidium bromide (d) induced by MT-21 was suppressed by the expression of dominant negative c-Jun. Furthermore, we examined the morphology and nuclear condensation of these cells by¯uorescence imaging analysis using Hoechst 33258. Nuclear condensation and the formation of the apoptotic bodies caused by MT-21-treatment were suppressed by the expression of the dominant negative c-Jun (Figure 8b) . Dominant negative c-Jun did not block the cleavage of Krs-1 and Krs-2 (data not shown). These results suggest that the activation of JNK by active Krs proteins is necessary for MT-21-induced apoptosis.
Discussion
The caspase cascade is activated by various stimuli including serum withdrawal, activation of Fas, ionizing radiation and chemical compounds (Darmon et al., 1996; Chinnaiyan et al., 1996; Dubrez et al., 1996; Erhards and Cooper, 1996; Hasegawa et al., 1996; Jacobson et al., 1996; Schlegel et al., 1996) . Fas activation is known to activate the caspase cascade by interacting directly with a signaling complex on the cell membrane (Boldin et al., 1996; Muzio et al., 1996) . Although Fas ligands may represent possible candidates for antitumor agents, most tumor cells express low levels of Fas. Moreover, the lack of small molecule has made Fas-based cancer therapy dicult because most Fas ligands are proteins. Because of these issues, chemical control of apoptosis has emerged as an important strategy for cancer therapy.
In previous studies, we discovered epolactaene, which has a g-lactam ring and an alkyl chain at the C-3 position, induced neurite outgrowth in SH-SY5Y cells (Kakeya et al., 1995) . In this study, we found that one of our synthetic epolactaene derivatives, MT-21, which has a g-lactam ring and an alkyl chain at the N-1 position, induced apoptosis in human leukemia HL-60 cells. Interestingly, MT-21 is not able to induce neurite outgrowth in PC12 cells. The alkyl group at N-1 position of the g-lactam ring was required, since any analog that has an alkyl group at position C-5 leads to the complete loss of the activity for neurite outgrowth or apoptosis induction. In particular, it is noteworthy that modi®cation of the length of the alkyl chain at the N-1 position signi®cantly changed the biological activity. We found in the present study that ROS were involved in MT-21-induced apoptosis in HL-60 cells because the apoptosis was diminished by NAC and atocopherol (Figure 2c ). In particular, we showed that ROS were required to activate caspase-3 during MT-21-induced apoptosis (Figure 4) . Moreover, we showed that apoptosis induced by MT-21 is dependent on caspase activation. Caspase-3 normally exists in the cytosolic fraction of cells as an inactive precursor, and it is activated proteolytically when cells are signaled to undergo apoptosis (Schlegel et al., 1996; Wang et al., 1996) . The 32 kDa precursor form of caspase-3 is cleaved at two aspartic residues and yield an active caspase-3 consisting of two proteolytic fragments, 20 kDa and a 12 kDa (Nicholson et al., 1995; Wang et al., 1996) . Considering these reports, we suspect that MT-21 activates a caspase cascade via ROS production. Because the mechanism by which ROS production is able to activate the caspase cascade during MT-21-induced apoptosis has not yet been clari®ed, identi®cation of this mechanism will be necessary in the future.
MT-21 also caused the activation of 36 kDa MBP kinase by caspase-activation via ROS production ( Figure 6 ). In addition, the appearance of the 36 kDa kinase activity correlated with the disappearance of a 60 kDa MBP kinase activity. In order to identify the 60 kDa kinase, we looked for a known kinase that migrated with this molecular mass, was sensitive to proteolysis yielding a catalytically active fragment of 36 kDa. One candidate was the Krs protein, a ubiquitous serinethreonine kinase about 60 kDa, which has a sequence homology to the yeast Ste20 kinase (Creasy and Cherno, 1995; Taylor et al., 1996; Kakeya et al., 1998) . Krs proteins consist of two family members Krs-1 and Krs-2, and both these proteins have a caspase-3 recognition sequence, namely DELD 322 and DEMD
326
. Krs proteins are cleaved by caspases and gave two fragments consisting of a regulatory domain that exists at Cterminus and the activated kinase domain (Creasy and Cherno, 1995; Taylor et al., 1996) . To con®rm whether the activation of Krs proteins by caspase-3 is required during MT-21-induced apoptosis, we tested the eect of a caspase inhibitor, or overexpression of kinase-inactive Krs proteins. The kinase-inactive Krs proteins substituted Arg for the Lys56 residue of Krs-1 or the Lys59 of Krs-2 are not able to bind to ATP and consequently lack kinase activity. When a caspase inhibitor Z-Asp was added or these kinase-inactive Krs proteins were expressed in HL-60 cells, the activation of the p36 kDa kinase and apoptosis-induction was almost completely suppressed. These results indicate that activation of Krs proteins is dependent on caspase activity and necessary for apoptosis induction by MT-21 (Figure 9) . Activation of JNK has been observed to correlate with the apoptosis induction of various stimuli, including nerve growth factor withdrawal, B-cell receptor cross-linking and Fas ligation (Xia et al., 1995; Cahill et al., 1996; Graves et al., 1996; Wilson et al., 1996; Juo et al., 1997) . Caspase inhibitors can block JNK activation induced by Fas cross-linking, indicating that this pathway may function downstream of caspase activation (Cahill, et al., 1996; Juo et al., 1997) . In fact, MT-21-induced JNK activation was suppressed by Z-Asp and by expression of kinase-inactive Krs proteins during the process of apoptotic induction (Figure 7b ). At the ®nal stage of our studies, two groups using a dierent approach showed the importance of MST/Krs in apoptosis. Lee et al. (1998) reported that one of the substrates of caspase-3 is MST/Krs, and Graves et al. (1998) reported that active MST1 activates MKK7, an upstream activator of JNK. Our observation in MT-21-induced apoptosis is consistent with their observations. However, in the present study, we proved newly that ROS is involved in MT-21-induced apoptosis and ROS produced by MT-21 activated downstream of caspase cascade and activated JNK via Krs proteins activation by caspase-mediated proteolysis. However, Graves et al. (1998) reported only about MST1/Krs2, whereas we proved newly there is no dierence between Krs-1 and Krs-2 on the mechanism of activation and its role by using with kinase-inactive Krs-1 or Krs-2 and it is necessary for the amounts of 36 kDa Krs proteins activated by caspase to induce apoptosis. Because MT-21 stimulates simple signal transduction pathway compared with Fas as shown in Figure 9 , the clari®cation of the mechanism of apoptosis induction by MT-21 provides opportunities to develop an apoptosis-inducing agent directed against cancer cells.
Materials and methods
Chemicals
MT-21 was synthesized as previously described (Kakeya et al., 1997) , solubilized in methanol and used for experiments. Z-Asp-CH 2 -DCB (Z-Asp) was purchased from Peptide Institute, Inc. (Osaka, Japan) and used as an inhibitor with a broad speci®city to various caspases. Anti-caspase-3 antibody, anti-PARP antibody, anti-Krs-1 antibody and anti-Krs-2 antibody were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Cells
Human promyelocytic leukemia HL-60 and U937 cells were cultured in RPMI-1640 medium supplemented with 10% FCS at 378C in 5% CO 2 humidi®ed atmosphere.
Analysis of DNA fragmentation by agarose gel electrophoresis
HL-60 cells were lysed with a solution consisting of 10 mM Tris-HCl, pH 8.0, 10 mM EDTA, 0.5% (w/v) SDS and 0.1% (w/v) RNase A, and incubated for 60 min at 508C. The lysate was incubated for an additional 60 min at 508C with 1 mg/ml proteinase K and phenol/chloroform extracted DNA was electrophoresed on a 2% (w/v) agarose gel in 40 mM Trisacetate, pH 7.5 containing 1 mM EDTA for 90 min at 50 V. After electrophoresis, DNA was visualized by ethidium bromide staining.
Evaluation of intracellular H 2 O 2
The cells were treated with chemicals in the presence of 5 mM DCFH-DA. The esteri®ed form of DCFH-DA can permeate cell membranes and then be deacetylated by intracellular esterases. The resulting compound is reactive with H 2 O 2 to Activation of Krs/MST during apoptosis M Watabe et al
give a¯uorescent compound, dichloro¯uorescein (Royall and Ischiropoulos, 1993 ). The amount of intracellular H 2 O 2 was detected by¯ow cytometry (Epics Elite; Coulter, Hialeah, FL, USA).
Preparation of cell lysate
HL-60 cells were lysed with 0.1 ml of lysis buer consisting of 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.15 M NaCl, 5 mg/ml aprotinin, 5 mg/ml leupeptin, 0.5 mM PMSF, 2 mM sodium orthovanadate, and 1% (w/v) Triton X-100. The cell lysate was centrifuged at 15 000 g for 20 min. The supernatant thus obtained was used for immunoblotting and measuring protein kinase activities.
Detection of MBP kinase activity in SDS-polyacrylamide gel
Separation gel containing 10% (w/v) polyacrylamide, 0.1% (w/v) SDS and 0.5 mg/ml MBP was prepared as described previously (Watabe et al., 1996) , and 40 mg of protein of cell lysates were subjected to electrophoresis according to the method of Laemmli (1970) . After electrophoresis, the gel was incubated for 1 h in 50 mM Tris-HCl, pH 8.0 containing 20% (v/v) isopropyl alcohol to remove SDS and then incubated for 1 h in buer A containing 50 mM Tris-HCl, pH 8.0, and 5 mM 2-mercaptoethanol. Subsequently, proteins in the gel were denatured for 1 h in buer A containing 6 M guanidine HCl. The denatured proteins were renatured by incubating the gel for 12 h at 48C in four changes of buer A containing 0.05% (w/v) Tween 20. The entire gel was then subjected to a kinase assay. After a 30-min preincubation at room temperature in buer B (40 mM HEPES, pH 7.5, 10 mM MgCl 2 , 2 mM dithiothreitol and 0.1 mM EGTA), the gel was incubated for 1 h in buer B containing 20 mM [g-32 P]ATP (25 mCi) at 308C. The gel was extensively washed with a solution consisting of 5% (w/v) trichloroacetic acid, 1% (w/v) sodium pyrophosphate, dried, and subjected to autoradiography at 7808C using Kodak X-Omat AR 5 X-ray ®lm and an intensifying screen. The incorporation of 32 P into proteins was quanti®ed by a Bio-imaging Analyzer BAS 2000 (Fuji Photo Film Co. Ltd., Japan).
Determination of JNK activity
JNK activity in the whole cell extracts (0.1 mg) was measured by incubation with 10 mg of GST-c-Jun (1-79) conjugated to glutathione-agarose beads (prepared according to the manufacturer's instructions, Pharmacia) for 1 h at 48C. The agarose beads were collected by quick microcentrifugation and washed 5 times with HEPES binding buer (20 mM HEPES, pH 8.0, 20 mM MgCl 2 , 0.1 mM EDTA, 50 mM NaCl, 0.05% Triton X-100). The ®nal wash was performed in kinase buer (20 mM HEPES, pH 8.0, 20 mM MgCl 2 , 20 mM b-glycerophosphate, 0.1 mM sodium vanadate, 2 mM dithiothreitol). The kinase reaction was initiated by resuspending the pelleted beads in 30 ml of kinase buer containing [g-32 P]ATP (20 mM, 0.5 mCi/reaction) for 10 min at 308C. The reaction was terminated by addition of 1 ml of the ice-cold HEPES binding buer. The beads were pelleted, resuspended in SDS sample buer, and boiled for 5 min. Proteins were separated by electrophoresis on a 10% SDSpolyacrylamide gel followed by autoradiography.
Immunoblotting
Cell lysates containing 20 mg of protein were subjected to SDS-polyacrylamide gel electrophoresis and separated. The proteins were then transferred to a polyvinylidene di¯uoride membrane (Millipore, MA, USA) with a semi-dry blotting apparatus at 2 mA/cm 2 constant current for 1 h. The membrane was ®rst washed with 20 mM Tris-HCl buer, pH 7.4 containing 0.15 M NaCl (TBS), and was then blocked with 3% (w/v) bovine serum albumin in TBS for 1 h at room temperature. The blocked membrane was subsequently probed for 1 h at room temperature with primary antibody, diluted 1 : 1000 in TBS containing 0.1% (w/v) bovine serum albumin. After washing with TBS containing 0.1% (w/v) Tween 20 (TTBS), the membrane was incubated for 1 h at room temperature with horseradish peroxidase-conjugated second antibody, diluted 1 : 2000 in TBS containing 0.1% (w/v) bovine serum albumin. After washing with TTBS, protein bands on the membrane were visualized by an ECL Western blotting detection system (DuPont NEN, Boston, MA, USA).
Cloning of human krs-1 and krs-2 cDNA Reverse transcription polymerase chain reaction (RT ± PCR) was used to obtain krs-1 and krs-2 cDNA (Watabe et al., 1998) . Total RNA was isolated from HL-60 cells and 1.5 mg RNA was incubated in a ®nal volume of 20 ml reaction mixture consisting of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 10 mM dithiothreitol, 3 mM MgCl 2 , 0.5 mM each deoxynucleoside triphosphate, 1 U/ml RNase inhibitor (Promega, Madison, WI, USA) and 20 pmol of oligo (dT) 16 primer at 958C for 5 min. The reaction mixture was then cooled to 428C for annealing. Complementary DNA was synthesized by incubating with 1 ml of Molony murine leukemia virus (MMLV) (200 units) reverse transcriptase (GIBCO ± BRL) at 428C for 60 min. MMLV reverse transcriptase was inactivated by heating at 958C for 10 min. The RT reaction mixture was diluted with 80 ml of PCR buer containing 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 1 mM MgCl 2 , 50 pmol of the forward primer (krs-1; AGCGGCCGCATGGAGCAGC-CGCCGGC, krs-2; AAAGCTTATGGAGACGGTACA-GCTGAG) and 50 pmol of reverse primer (krs-1; ATCTA-GAGAAATTAGACTCAAAGTTTTGC, krs2; ATCTA-GAGCCTGGCCTTGCTCAGAAG). PCR reactions were performed in the presence of 0.5 U Ampli Taq Gold (Perkin Elmer Cetus) for 40 cycles using a step program (958C, 1 min; 558C, 1 min; 728C, 2 min), followed by a 7 min ®nal extension at 728C. The 1.5 kb NotI ± XbaI fragment and 1.5 HindIII ± XbaI fragment encoding each entire human krs-1 and krs-2 were obtained.
In vitro mutagenesis and plasmid construction
The mutagenesis of Lys56 to Arg; krs-1 or Lys59 to Arg; krs-2 for a HindIII ± XbaI fragment of human krs-1 or krs-2 cDNA was performed by the megaprimer method of Datta using a mutagenic primer for krs-1 (5'-CAACAGG-TACTTGTCTAATTGCGACAACTT-3') or Krs-2 (5'-TCCACA GGAACTTGCCTA ATAGCAACA ATCTGG -3') (Datta, 1995) . Lys56 of krs-1, and Lys59 of krs-2 are located in the ATP-binding site and their replacement by arginine made Krs kinase inactive (Creasy et al., 1996) . The entire sequence of krs-1 or krs-2 was analysed to ensure that only the desired mutation had been introduced. The 1.5-kb NotI ± XbaI fragment or 1.5 kb HindIII ± XbaI fragment that encoded kinase inactive human Krs-1 or Krs-2 was cloned into the HindIII ± XbaI or NotI ± XbaI site of pRc/CMV.
Transfection of HL-60 cells
HL-60 cells were transfected in 60 mm dishes with 2 mg of the appropriate plasmids using 10 ml of FuGENE TM 6 (Boehringer Mannheim, IN, USA) according to the manufacturer's instructions.
